XOMA Royalty Corp Completes Asset Acquisition
Ticker: XOMAP · Form: 8-K · Filed: Sep 23, 2025 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Royalty Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0075, $0.05, $0.0001, $1.95 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, royalty-interests, assets
TL;DR
XOMA just bought some royalty assets, details TBD.
AI Summary
On September 17, 2025, XOMA Royalty Corp. completed the acquisition of certain royalty interests from an unnamed seller. The filing does not disclose the specific dollar amount of the transaction, but it is categorized under 'Completion of Acquisition or Disposition of Assets' and 'Other Events'.
Why It Matters
This acquisition could expand XOMA Royalty Corp.'s portfolio of royalty interests, potentially increasing future revenue streams from the acquired assets.
Risk Assessment
Risk Level: medium — The lack of specific financial details and the nature of royalty asset acquisitions introduce uncertainty regarding the deal's value and future performance.
Key Players & Entities
- XOMA Royalty Corp. (company) — Filer of the 8-K report
- September 17, 2025 (date) — Date of the earliest event reported
FAQ
What specific royalty interests did XOMA Royalty Corp. acquire?
The filing does not specify the exact nature or type of royalty interests acquired.
What was the total dollar amount of the acquisition?
The filing does not disclose the specific dollar amount of the transaction.
Who was the seller of the royalty interests?
The filing does not identify the seller of the royalty interests.
What is the expected impact of this acquisition on XOMA Royalty Corp.'s revenue?
The filing does not provide specific projections for the revenue impact of this acquisition.
Are there any financial statements or exhibits attached to this filing related to the acquisition?
The filing indicates 'Financial Statements and Exhibits' as an item, but the specific content is not detailed in the provided text.
Filing Stats: 1,807 words · 7 min read · ~6 pages · Grade level 14.4 · Accepted 2025-09-23 17:13:38
Key Financial Figures
- $0.0075 — nge on which registered Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
- $0.0001 — nding shares of common stock, par value $0.0001 per share (the " Shares "), for a price
- $1.95 — Shares "), for a price per Share of (i) $1.95 in cash (the " Cash Amount "), payable
Filing Documents
- d48493d8k.htm (8-K) — 41KB
- d48493dex21.htm (EX-2.1) — 685KB
- d48493dex22.htm (EX-2.2) — 146KB
- 0001193125-25-213583.txt ( ) — 1247KB
- xoma-20250917.xsd (EX-101.SCH) — 4KB
- xoma-20250917_def.xml (EX-101.DEF) — 14KB
- xoma-20250917_lab.xml (EX-101.LAB) — 24KB
- xoma-20250917_pre.xml (EX-101.PRE) — 15KB
- d48493d8k_htm.xml (XML) — 8KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (a)Financial Statements of Business Acquired. The financial statements of HilleVax and related notes as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements of HilleVax as of June 30, 2025 and 2024 and for the periods then ended and related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form 8-K within the period specified in Item 9.01(a)(3) of Form 8-K. (b)Pro Forma Financial Information. The unaudited pro forma condensed combined financial information of XOMA and HilleVax as of and for the six months ended June 30, 2025 and the year ended December 31, 2024 and the related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form 8-K within the period specified in Item 9.01(a)(3) of Form 8-K. (d)Exhibits. Exhibit No. Description 2.1 Agreement and Plan of Merger, dated August 4, 2025, by and among XOMA Royalty Corporation, HilleVax, Inc. and XRA 4 Corp.* 2.2 Contingent Value Rights Agreement, dated September 17, 2025, by and among XOMA Royalty Corporation, XRA 4 Corp., Broadridge Corporate Issuer Solutions, LLC and Dr. Robert Hershberg, solely in his capacity as the initial representative, agent and attorney-in-fact of the Holders. 99.1 Press Release issued by XOMA Royalty Corporation on September 17, 2025 (incorporated herein by reference to Exhibit (a)(5)(B) to the Schedule TO-T/A filed by XOMA Royalty Corporation on September 17, 2025). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Certain exhibits, annexes and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted exhibits, annexes and schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA ROYALTY CORPORATION Date: September 23, 2025 By: /s/ Owen Hughes Name: Owen Hughes Title: Chief Executive Officer